January 13, 2020 | Daily JAM, NKTR, Stock Alerts, Volatility |
I understand why the U.S. Food & Drug Administration has moved so slowly on a decision on Nektar Therapeutic's (NKTR) new non-addictive opioid NKTR-181. The last thing the FDA wants to do in the midst of epidemic of opioid addiction is to approve a drug that might...
August 13, 2019 | Daily JAM, NKTR, Stock Alerts, Volatility |
What we know about Nektar Therapeutics (NKTR) is pretty clear. On Thursday of last week, August 8, trading in shares of Nektar were halted on news from the company had manufacturing problems that resulted in some patients enrolled in the clinical trials for the...
June 12, 2019 | Daily JAM, NKTR, Stock Alerts |
Shares of Nektar Therapeutics (NKTR) have been bumping along between $32 and $34 for two months now, but the company continues to take steps to prepare for the likely August approval of NKTR-181, a new non-addictive opioid. Nektar has formed Inheris Biopharma, a...
August 20, 2018 | Daily JAM, NKTR, Stock Alerts |
I'm on vacation through August 26. I'm trying to use this down time to catch up on earnings results that I missed during the very busy second quarter earning season. After the market close on Wednesday, August 8, Nectar Therapeutics (NKTR) reported earnings of $5.33 a...
June 14, 2018 | Daily JAM, NKTR, Stock Alerts |
Frankly, my holdings of shares and options on Nektar Therapeutics (NKTR) are driving me nuts. The stock is just so volatile that I can barely stand it even though I'm comfortable with the long-term trajectory of the company's new non-addictive opioid and its leading...
October 31, 2017 | Daily JAM, NKTR, Stock Alerts |
This is a tough one. A very tough one. I added Netkar options (NKTR180119C00022000)--the January 19, 2018 call at $22--to my volatility portfolio back on May 16, 2017 at a price of $2.64 (the closing options price on that day.) Â Today, using the last price again on...
August 22, 2017 | Daily JAM, NKTR, Stock Alerts |
Biotechs--and indeed any high price-to-earnings stocks perceived as risky--have taken more than their share of punishment in the nervous sell off of the last few weeks. Nektar Therapeutics (NKTR), for example, closed yesterday August 21 at $17.79. That's down from...